Utah Retirement Systems Incyte Corp Transaction History

Utah Retirement Systems

$8.7 Billion
Q3 2024

A detailed history of Utah Retirement Systems transactions in Incyte Corp stock. As of the latest transaction made, Utah Retirement Systems holds 26,329 shares of INCY stock, worth $2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

26,329

Previous 30,529 13.76%

Holding current value

$2 Million

Previous $1.85 Million 5.95%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $240,786 - $288,162	-4,200 Reduced 13.76%	26,329 $1.74 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $66,534 - $82,875	-1,300 Reduced 4.08%	30,529 $1.85 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $10,432 - $12,838	200 Added 0.63%	31,829 $2 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $5,777 - $6,593	100 Added 0.32%	31,629 $1.83 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $60,950 - $75,510	-1,000 Reduced 3.07%	31,529 $1.96 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $14,046 - $17,202	200 Added 0.62%	32,529 $2.35 Million
Q4 2022 Feb 15, 2023	SELL	$67.18 - $84.11 $40,308 - $50,466	-600 Reduced 1.82%	32,329 $2.6 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $13,236 - $16,572	200 Added 0.61%	32,929 $2.19 Million
Q2 2022 Aug 16, 2022	SELL	$66.18 - $83.18 $13,236 - $16,636	-200 Reduced 0.61%	32,729 $2.49 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $39,612 - $47,825	-600 Reduced 1.79%	32,929 $2.62 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $6,334 - $7,411	100 Added 0.3%	33,529 $2.46 Million
Q3 2021 Nov 16, 2021	SELL	$68.67 - $84.02 $123,606 - $151,236	-1,800 Reduced 5.11%	33,429 $2.3 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $7,987 - $8,753	-100 Reduced 0.28%	35,229 $2.96 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $83,622 - $110,550	-1,100 Reduced 3.02%	35,329 $2.87 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $129,183 - $156,320	1,600 Added 4.59%	36,429 $3.17 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $17,014 - $21,938	200 Added 0.58%	34,829 $3.13 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $51,926 - $76,251	700 Added 2.06%	34,629 $3.6 Million
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $6,318 - $8,597	100 Added 0.3%	33,929 $2.49 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $21,845 - $25,956	300 Added 0.89%	33,829 $2.51 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $31,540 - $38,052	429 Added 1.3%	33,529 $2.85 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $25,424 - $35,268	400 Added 1.22%	33,100 $2.85 Million
Q4 2018 Feb 08, 2019	BUY	$58.5 - $69.94 $5,850 - $6,994	100 Added 0.31%	32,700 $2.08 Million
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $6,175 - $7,423	100 Added 0.31%	32,600 $2.25 Million
Q2 2018 Aug 10, 2018	BUY	$60.85 - $83.98 $12,170 - $16,796	200 Added 0.62%	32,500 $2.18 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $140,340 - $174,900	1,500 Added 4.87%	32,300 $3.06 Million
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $3.36 Million - $4.26 Million	30,800	30,800 $3.6 Million

Others Institutions Holding INCY

# of Institutions

641

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Incyte Corp Transaction History